This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
Pediatric Neurology Briefs (Jul 1991)
Affiliations
Read online
An open label trial of fluoxetine (20-40 mg/d) was conducted in 32 Tourette syndrome patients with obsessive-compulsive disorder at the Department of Neurology, University of Rochester School of Medicine, NY.